Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis

c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence

(2015) Jaudah Al-Maghrabi et al.   BMC CANCER

Cyclooxygenase-2 Expression in Urinary Bladder Transitional Cell Carcinoma and its Association with Clinicopathological Characteristics

(2013) Hedieh Moradi Tabriz et al.   Asian Pacific Journal of Cancer Prevention

Cyclooxygenase-2 Expression in Bladder Cancer and Patient Prognosis: Results from a Large Clinical Cohort and Meta-Analysis

(2012) Maciej J. Czachorowski et al.   PLoS One

Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma

(2012) Jaudah Al-Maghrabi   WORLD JOURNAL OF GASTROENTEROLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2

(2010) Anis Aziz et al.   BJU INTERNATIONAL

Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for urinary bladder cancer in North India

(2010) Ruchika Gangwar et al.   SURGERY

Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma

(2009) MONA MOUSSA et al.   APMIS

Overexpression of cyclooxygenase-2 in urothelial carcinoma in conjunction with tumor-associated-macrophage infiltration, hypoxia-inducible factor-1α expression, and tumor angiogenesis

(2009) WAN-TZU CHEN et al.   APMIS

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

(2009) A. Greenhough et al.   CARCINOGENESIS

Cyclooxygenase-2 expression in invasive transitional cell carcinoma of the urinary bladder

(2008) Yamada   Molecular Medicine Reports